Nuvalent News

Nuvalent | 8-K: Current report

Sep 18 04:25

Nuvalent | 8-K: Current report

Sep 16 18:21

Nuvalent | 8-K: Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2024 Financial Results

Aug 8 18:44

Nuvalent | 8-K: Current report

Jul 22 18:37

Nuvalent | 8-K: Current report

Jun 15 04:11

Nuvalent | 8-K: Current report

May 17 04:14

Nuvalent | 8-K: Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results

May 9 18:42

Nuvalent | DEFA14A: Others

Apr 27 04:18

Nuvalent | DEF 14A: Definitive information statements

Apr 27 04:16

Nuvalent | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 20:05

Nuvalent | 8-K: Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27 19:40

Nuvalent | 8-K: Current report

Jan 9 13:00

Nuvalent | 8-K: Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results

Nov 14, 2023 19:45

Nuvalent | 8-K: Current report

Oct 18, 2023 04:07

Nuvalent | 8-K: Current report

Oct 13, 2023 18:40

Nuvalent | 8-K: Current report

Oct 5, 2023 04:05

Nuvalent | 8-K: Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results

Aug 10, 2023 18:45

Nuvalent | 8-K: Current report

Jun 17, 2023 04:08

Nuvalent | 8-K: Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results

May 11, 2023 18:39

Nuvalent | DEFA14A: Others

Apr 29, 2023 04:14